We are live on ! Find out more
TIL icon

Instil Bio

62 hedge funds and large institutions have $45.3M invested in Instil Bio in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 25 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more call options, than puts

Call options by funds: $6K | Put options by funds: $1K

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.39% less ownership

Funds ownership: 3.55%3.16% (-0.39%)

15% less funds holding

Funds holding: 7362 (-11)

26% less capital invested

Capital invested by funds: $60.9M → $45.3M (-$15.6M)

46% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 24

68% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 25

Holders
62
Holders Change
-11
Holders Change %
-15.07%
% of All Funds
0.97%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
8
Reduced
25
Closed
24
Calls
$6K
Puts
$1K
Net Calls
+$5K
Net Calls Change
-$5K

TIL Hedge Fund Activity: Q2 2023 in Review

62 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q2 2023, worth a combined $45.3M — down 26% from $60.9M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of TIL and 13 opened new positions — a net loss of 11 holders — while 25 trimmed existing stakes and 8 added.

The largest buyer was Millennium Management, adding an estimated $322K. The largest seller was Citigroup, cutting an estimated $2.46M.

  • 62 institutional investors held Instil Bio (TIL) as of Q2 2023, down from 73 in Q1 2023.
  • Funds reported $45.3M of Instil Bio stock for Q2 2023, down 26% quarter-over-quarter.
  • 13 funds opened new Instil Bio positions in Q2 2023 and 24 closed out, a net change of -11 holders.
  • The largest Instil Bio buyer in Q2 2023 was Millennium Management, an estimated $322K added.
  • The largest Instil Bio seller in Q2 2023 was Citigroup, an estimated $2.46M sold.

Based on aggregated 13F filings for Q2 2023.